AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL · Real-Time Price · USD
3.160
+0.380 (13.67%)
At close: Feb 6, 2026, 4:00 PM EST
3.220
+0.060 (1.91%)
After-hours: Feb 6, 2026, 7:52 PM EST
AbCellera Biologics Employees
AbCellera Biologics had 596 employees as of December 31, 2024. The number of employees increased by 10 or 1.71% compared to the previous year.
Employees
596
Change (1Y)
10
Growth (1Y)
1.71%
Revenue / Employee
$59,270
Profits / Employee
-$288,049
Market Cap
945.90M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 596 | 10 | 1.71% |
| Dec 31, 2023 | 586 | 91 | 18.38% |
| Sep 30, 2023 | 630 | 155 | 32.63% |
| Jun 30, 2023 | 590 | 140 | 31.11% |
| Mar 31, 2023 | 525 | 125 | 31.25% |
| Dec 31, 2022 | 495 | 109 | 28.24% |
| Sep 30, 2022 | 475 | 115 | 31.94% |
| Jun 30, 2022 | 450 | 148 | 49.01% |
| Mar 31, 2022 | 400 | 194 | 94.17% |
| Dec 31, 2021 | 386 | 180 | 87.38% |
| Sep 30, 2021 | 360 | 186 | 106.90% |
| Jun 30, 2021 | 302 | 128 | 73.56% |
| Dec 31, 2020 | 206 | 99 | 92.52% |
| Sep 30, 2020 | 174 | 67 | 62.62% |
| Jun 30, 2020 | 174 | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 427 |
| Vir Biotechnology | 408 |
| UroGen Pharma | 287 |
| Geron | 229 |
| ARS Pharmaceuticals | 167 |
| CytomX Therapeutics | 121 |
| Ventyx Biosciences | 83 |
| ArriVent BioPharma | 52 |
ABCL News
- 16 days ago - AbCellera to Report Full Year 2025 Financial Results on February 24, 2026 - Business Wire
- 23 days ago - AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 26 days ago - AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - Business Wire
- 7 weeks ago - AbCellera and Bruker Reach Global Settlement of Patent Litigation - Business Wire
- 2 months ago - AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - Business Wire
- 2 months ago - AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 3 months ago - AbCellera Appoints Dr. Stephen Quake to its Board of Directors - Business Wire